Most ischemic stroke readmissions aren't preventable, study suggests | ACP Hospitalist Weekly | ACP Hospitalist
Only a small proportion of ischemic stroke readmissions are preventable, a new study found.
Mobilization is generally considered appropriate therapy, but there is no firm guidance on how early it should begin.
Focused guideline update addresses endovascular treatment for early management of acute ischemic stroke | ACP Hospitalist Weekly | ACP Hospitalist
A new guideline update from the American Heart Association/American Stroke Association describes when to use endovascular therapy for stroke.
These cases and commentary, which address stroke, are excerpted from ACP's Medical Knowledge Self-Assessment Program (MKSAP15).
New risk score for in-hospital pneumonia after acute ischemic stroke | ACP Hospitalist Weekly | ACP Hospitalist
Researchers have developed a 34-point risk score to predict in-hospital pneumonia after acute ischemic stroke that appears to have better discrimination than older scores.
Now that endovascular therapy has been officially endorsed by experts, how should hospitals respond?
Alteplase treatment associated with slightly improved long-term survival after ischemic stroke | ACP Hospitalist Weekly | ACP Hospitalist
Patients randomized to alteplase in addition to standard care had a significantly higher mortality rate during the first 7 days after treatment, but a significantly lower risk of death between 8 days and 3 years after treatment.
Alternative antiplatelet agents, alone or as adjunct, more effective than continuing aspirin monotherapy after new ischemic stroke | ACP Hospitalist Weekly | ACP Hospitalist
Study authors noted that, despite the overall benefits, on the outcome of stroke recurrence alone, the difference between switching to other agents and continuing monotherapy was not statistically significant, possibly due to low statistical power.
Recent studies have found that stroke patients admitted to the hospital at night and on the weekends are more likely to die than those admitted on weekdays. Why does mortality vary at different times of the day and week, and how can hospitals change
COX-2 inhibitors associated with greater risk for death after ischemic stroke | ACP Hospitalist Weekly | ACP Hospitalist
Cyclooxygenase (COX)-2 inhibitor use before hospital admission for ischemic stroke was associated with a higher 30-day mortality rate, according to a new study.